SANUWAVE Health, Inc. (SNWV) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, SANUWAVE Health, Inc.'s filing signal continuing positive.

SANUWAVE Health, Inc. is a medical device company focused on regenerative medicine for wound care, utilizing its patented and FDA-cleared UltraMIST(R) system. This non-contact, pain-free ultrasound technology promotes tissue repair and regeneration for acute and chronic wounds, including diabetic foot ulcers and pressure injuries. The company operates on a "razor and blade" model, selling systems and recurring consumables, which represented 99% of its $44.1 million revenue in 2025. With over 60 patents, SANUWAVE markets its system through direct sales, distributors, and resellers primarily within the United States, targeting a large and growing wound care market.

Revenue is primarily driven by the sale of UltraMIST(R) systems and, more significantly, by recurring sales of sterile, single-use applicators (consumables).